Health Care & Life Sciences » Biotechnology | Prescient Therapeutics Ltd.

Prescient Therapeutics Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,808.60
1,046.70
9,753.60
7,665.40
5,505.90
Total Accounts Receivable
126.80
216.40
664.30
1,079.80
984.70
Other Current Assets
-
261.70
49.00
115.50
131.00
Total Current Assets
3,935.30
1,524.70
10,467.00
8,860.70
6,621.60
Net Property, Plant & Equipment
-
-
1.10
2.20
2.30
Intangible Assets
1,344.40
3,366.90
3,366.90
3,366.90
3,366.90
Total Assets
5,279.70
4,891.60
13,835.10
12,229.80
9,990.80
ST Debt & Current Portion LT Debt
-
-
-
-
56.00
Accounts Payable
-
-
336.60
340.80
243.20
Other Current Liabilities
252.90
438.60
485.60
99.80
244.50
Total Current Liabilities
252.90
438.60
822.20
440.60
543.80
Provision for Risks & Charges
-
2.50
0.30
4.20
7.80
Total Liabilities
252.90
441.10
822.60
444.90
551.60
Common Equity (Total)
5,026.80
4,450.50
13,012.50
11,785.00
9,439.30
Total Shareholders' Equity
5,026.80
4,450.50
13,012.50
11,785.00
9,439.30
Total Equity
5,026.80
4,450.50
13,012.50
11,785.00
9,439.30
Liabilities & Shareholders' Equity
5,279.70
4,891.60
13,835.10
12,229.80
9,990.80

About Prescient Therapeutics

View Profile
Address
100 Albert Road
South Melbourne Victoria (VIC) 3205
Australia
Employees -
Website http://www.prescienttherapeutics.com
Updated 07/08/2019
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded May 22, 1986 and is headquartered in Perth, Australia.